Research & Literature

Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients.

Kristensen SB, Hess S, Petersen H, Høilund-Carlsen PF

European journal of nuclear medicine and molecular imaging 2015; (42(13)):2056-63 doi:10.1007/s00259-015-3126-2.

Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.

Vatankulu B, Yilmaz Aksoy S, Asa S, et al.

Revista espanola de medicina nuclear e imagen molecular 2016; (35(1)):17-21.

[Sensory neuronopathy. Its recognition and early treatment].

Zuberbuhler P, Young P, León Cejas LV, et al.

Medicina 2015; (75(5)):297-302.

Autonomic Neuropathy.

Dineen J, Freeman R

Seminars in neurology 2015; (35(4)):458-68 doi:10.1055/s-0035-1558983.

[Disturbance in ADL from Chemotherapy-induced Peripheral Neuropathy and Quality of Life in Cancer Patients: The Mediating Effect of Psychological Distress].

Kim KY, Lee SH, Kim JH, Oh PJ

Journal of Korean Academy of Nursing 2015; (45(5)):661-70 doi:10.4040/jkan.2015.45.5.661.

Distal Symmetric Polyneuropathy: A Review.

Callaghan BC, Price RS, Feldman EL

JAMA 2015; (314(20)):2172-81 doi:10.1001/jama.2015.13611.

Small Cell Lung Cancer Accompanied by Tonsillar Metastasis and Anti-Hu Antibody-Associated Paraneoplastic Neuropathy: A Rare Case Report With Long-Term Survival.

Ni J, Weng L, Liu M, et al.

Medicine 2015; (94(50)):e2291 doi:10.1097/MD.0000000000002291.

Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.

Corsini E, Gaviani P, Chiapparini L, et al.

Journal of neuroimmunology 2016; (290()):119-22.

Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies.

Antoine JC, Robert-Varvat F, Maisonobe T, et al.

Journal of the neurological sciences 2016; (361()):187-91.

Cardiac Involvement in Peripheral Neuropathies.

Burakgazi AZ, AlMahameed S

Journal of clinical neuromuscular disease 2016; (17(3)):120-8 doi:10.1097/CND.0000000000000106.

Guillain-Barré syndrome.

Willison HJ, Jacobs BC, van Doorn PA

Lancet (London, England) 2016; (388(10045)):717-27.

Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features.

Waheed W, Boyd J, Khan F, et al.

BMJ case reports 2016; (2016()).

Microtubule-associated protein 1B: Novel paraneoplastic biomarker.

Gadoth A, Kryzer TJ, Fryer J, et al.

Annals of neurology 2017; (81(2)):266-277 doi:10.1002/ana.24872.

18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis.

García Vicente AM, Delgado-Bolton RC, Amo-Salas M, et al.

European journal of nuclear medicine and molecular imaging 2017; (44(9)):1575-1587 doi:10.1007/s00259-017-3722-4.

Synchronous Adie's syndrome and type 1 antineuronal nuclear antibody (anti-Hu)-related paraneoplastic neurological syndromes as predictors of complete response in limited-stage small-cell lung cancer: A case report.

Sreter KB, Barisic B, Barisic Kutija M, et al.

Molecular and clinical oncology 2017; (6(6)):921-924 doi:10.3892/mco.2017.1248.

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.

Starobova H, Vetter I

Frontiers in molecular neuroscience 2017; (10()):174 doi:10.3389/fnmol.2017.00174.

Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis.

Zis P, Paladini A, Piroli A, et al.

Pain and therapy 2017; (6(2)):143-151 doi:10.1007/s40122-017-0076-3.

Immune-mediated disorders.

Höftberger R, Lassmann H

Handbook of clinical neurology 2017; (145()):285-299 doi:10.1016/B978-0-12-802395-2.00020-1.

Paraneoplastic Disorders.

Lancaster E

Continuum (Minneapolis, Minn.) 2017; (23(6, Neuro-oncology)):1653-1679 doi:10.1212/CON.0000000000000542.

Sensory neuronopathy associated with cholangiocarcinoma diagnosed 6 years after symptom onset.

Rossor AM, Blake J, Pissanou T, Reilly MM

BMJ case reports 2017; (2017()) doi:10.1136/bcr-2016-217844.

[Paraneoplastic cerebellar degeneration (PCD) - an interdisciplinary challenge in neurology, oncology and palliative care].

Burger S, Lorenzl S

Wiener medizinische Wochenschrift (1946) 2018; (168(7-8)):193-198 doi:10.1007/s10354-018-0624-4.

MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review.

Ricigliano VAG, Fossati B, Saraceno L, et al.

Frontiers in neuroscience 2018; (12()):17 doi:10.3389/fnins.2018.00017.

Paraneoplastic sensorimotor polyneuropathy in prostatic adenocarcinoma: A case report.

Choi JK, Kim WJ, Jeon JY

Medicine 2018; (97(15)):e0030 doi:10.1097/MD.0000000000010030.

A Case Report of Pediatric Paraneoplastic Dysautonomia.

Harer K, Mann J, Muhlbauer N, et al.

Pediatric emergency care 2020; (36(12)):e742-e744 doi:10.1097/PEC.0000000000001558.

[Anti-Hu antibody positive sensory neuronopathy causing painful legs and moving toes (PLMT) in a 75-year-old female with small cell lung cancer (SCLC)].

Tsujimoto Y, Hao A, Sato T, et al.

Rinsho shinkeigaku = Clinical neurology 2018; (58(11)):677-681 doi:10.5692/clinicalneurol.cn-001198.

[Acute sensory neuropathy associated with Hodgkin's lymphoma: a case study].

Yokota Y, Mitsuke K, Minami H, et al.

Rinsho shinkeigaku = Clinical neurology 2019; (59(6)):349-355 doi:10.5692/clinicalneurol.cn-001271.

Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy.

Zekeridou A, Lennon VA

Mayo Clinic proceedings 2019; (94(9)):1865-1878 doi:10.1016/j.mayocp.2019.02.003.

F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET Access Program, with systematic review and meta-analysis.

Harlos C, Metser U, Poon R, et al.

Current oncology (Toronto, Ont.) 2019; (26(4)):e458-e465 doi:10.3747/co.26.4583.

Proactive Rehabilitation for Chemotherapy-Induced Peripheral Neuropathy.

Knoerl R, Gilchrist L, Kanzawa-Lee GA, et al.

Seminars in oncology nursing 2020; (36(1)):150983 doi:10.1016/j.soncn.2019.150983.

Long lasting trigeminal neuropathy, limbic encephalitis and abdominal ganglionitis without primary cancer: An atypical case of Hu-antibody syndrome.

De Schamphelaere E, Sieben A, Heyndrickx S, et al.

Clinical neurology and neurosurgery 2020; (194()):105849 doi:10.1016/j.clineuro.2020.105849.

[A case of paraneoplastic sensory neuronopathy with anti-Hu antibody associated with large cell neuroendocrine carcinoma of the endometrium].

Kato R, Aoyama N, Mizutani S, et al.

Rinsho shinkeigaku = Clinical neurology 2020; (60(6)):441-445 doi:10.5692/clinicalneurol.60.cn-001393.

Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis.

Dubey D, Wilson MR, Clarkson B, et al.

JAMA neurology 2020; (77(11)):1420-1429 doi:10.1001/jamaneurol.2020.2231.

The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested.

Ruiz-García R, Martínez-Hernández E, Saiz A, et al.

Frontiers in immunology 2020; (11()):1482 doi:10.3389/fimmu.2020.01482.

Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments.

Shah S, Vazquez Do Campo R, Kumar N, et al.

Neurology 2021; (96(4)):e632-e639 doi:10.1212/WNL.0000000000011218.

Paraneoplastic Disorders of the Nervous System.

Flanagan EP

Continuum (Minneapolis, Minn.) 2020; (26(6)):1602-1628 doi:10.1212/CON.0000000000000941.

A Rare Case of Sensory Neuropathy Associated with Transitional Cell Carcinoma of the Bladder.

Ketineni S, Kodali S, Gorantla S

Case reports in oncology 2020; (13(3)):1397-1401 doi:10.1159/000510742.

Sensory neuronopathies: A case series and literature review.

Sancho Saldaña A, Mahdi-Rogers M, Hadden RD

Journal of the peripheral nervous system : JPNS 2021; (26(1)):66-74 doi:10.1111/jns.12433.

A case of IVIg responsive paraneoplastic SOX1 peripheral neuropathy in a male with breast carcinoma.

Beer R, O'Gorman C, Horwood K, Blum S

Journal of neuroimmunology 2021; (352()):577492 doi:10.1016/j.jneuroim.2021.577492.

Sensory neuronopathies: new genes, new antibodies and new concepts.

Fargeot G, Echaniz-Laguna A

Journal of neurology, neurosurgery, and psychiatry 2021; doi:10.1136/jnnp-2020-325536.

Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain-Narrative Review.

Kocot-Kępska M, Zajączkowska R, Mika J, et al.

Pharmaceutics 2021; (13(4)) doi:10.3390/pharmaceutics13040450.

Cancer and Peripheral Nerve Disease.

Sarezky J, Sachs G, Elinzano H, Stavros K

Clinics in geriatric medicine 2021; (37(2)):289-300 doi:10.1016/j.cger.2021.01.003.

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

Graus F, Vogrig A, Muñiz-Castrillo S, et al.

Neurology(R) neuroimmunology & neuroinflammation 2021; (8(4)) doi:10.1212/NXI.0000000000001014.

Diffuse Large B-Cell Lymphoma Presenting as an Unusual Paraneoplastic Neurologic Syndrome Affecting the Central and Peripheral Nervous Systems.

Sorrentino AD, Kelkar AH, Dang NH

Cureus 2021; (13(4)):e14590 doi:10.7759/cureus.14590.

Exercise as Treatment for Neuropathy in the Setting of Diabetes and Prediabetic Metabolic Syndrome: A Review of Animal Models and Human Trials.

Singleton JR, Foster-Palmer S, Marcus RL

Current diabetes reviews 2022; (18(5)):e230921196752 doi:10.2174/1573399817666210923125832.

Paraneoplastic sensorimotor neuropathy and ventral cauda equina nerve root enhancement as initial presentation of small cell lung carcinoma: a case study.

Alsaeed M, Lim CAR, Plecash A, Chen T

BMC neurology 2021; (21(1)):374 doi:10.1186/s12883-021-02404-4.

CRMP5 Antibodies-Diagnostic Challenges.

Totland C, Haugen M, Vedeler C

Frontiers in neurology 2021; (12()):729075 doi:10.3389/fneur.2021.729075.

Paraneoplastic Neuropathies: What's New Since the 2004 Recommended Diagnostic Criteria.

Zoccarato M, Grisold W, Grisold A, et al.

Frontiers in neurology 2021; (12()):706169 doi:10.3389/fneur.2021.706169.

Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes.

Bastiaansen AEM, de Jongste AHC, de Bruijn MAAM, et al.

Neuro-oncology advances 2021; (3(1)):vdab145 doi:10.1093/noajnl/vdab145.

Update on Paraneoplastic Cerebellar Degeneration.

Loehrer PA, Zieger L, Simon OJ

Brain sciences 2021; (11(11)) doi:10.3390/brainsci11111414.

Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China.

Cai MT, Qiao S, Lai QL, et al.

Frontiers in immunology 2022; (13()):790400 doi:10.3389/fimmu.2022.790400.

Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.

de Rojas Leal C, Lage-Sánchez JM, Pinel-Ríos J, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(8)):4841-4845 doi:10.1007/s10072-022-06075-y.

Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders.

Chiang JCB, Arnold R, Dhanapalaratnam R, et al.

Pharmaceuticals (Basel, Switzerland) 2022; (15(5)) doi:10.3390/ph15050607.

Successful Treatment of Paraneoplastic Neuropathy and Pruritis With Scrambler Therapy: A Case Report.

Murphy TK, Pardo CA, Roda RH, et al.

Cureus 2022; (14(7)):e26861 doi:10.7759/cureus.26861.

Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4-6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo.

Myftiu B, Hundozi Z, Sermaxhaj F, et al.

Medical science monitor : international medical journal of experimental and clinical research 2022; (28()):e937856 doi:10.12659/MSM.937856.

Whole-body computed tomography as first-line imaging procedure to exclude cancer in patients with neurological suspicion of paraneoplastic syndromes: shall clinical practice adhere to recommendations?

Parillo M, Quattrocchi CC, Pilato F, et al.

Radiography (London, England : 1995) 2023; (29(1)):8-13 doi:10.1016/j.radi.2022.09.001.

Single-Center Retrospective Analysis of Paraneoplastic Syndromes with Peripheral Nerve Damage.

Tian J, Cao C, Miao R, et al.

Brain sciences 2022; (12(12)) doi:10.3390/brainsci12121656.

Rapidly Progressive Paraneoplastic Neuropathy Associated with Renal Cell Carcinoma: A Case Report.

Shah D, Trivedi J, Vernino S, Khan S

Journal of cancer science and clinical therapeutics 2022; (6(3)):333-335 doi:10.26502/jcsct.5079171.

Persistent pain and numbness in the extremities of an adult due to paraneoplastic peripheral neuropathy caused by olfactory neuroblastoma: A case report.

Liang W, Wang Y, Sun W, et al.

Frontiers in neurology 2022; (13()):1002076 doi:10.3389/fneur.2022.1002076.

Dysautonomia associated with immune checkpoint inhibitors.

Tezuka T, Okuzumi S, Nakashima C, et al.

Journal of neurology 2023; (270(7)):3413-3423 doi:10.1007/s00415-023-11667-5.

An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.

Wang S, Hou H, Tang Y, et al.

Neural regeneration research 2023; (18(11)):2357-2364 doi:10.4103/1673-5374.371400.

Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis.

Villagrán-García M, Farina A, Muñiz-Castrillo S, et al.

Brain communications 2023; (5(5)):fcad247 doi:10.1093/braincomms/fcad247.

Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes.

Villagrán-García M, Farina A, Campetella L, et al.

Revue neurologique 2024; (180(1-2)):107-116 doi:10.1016/j.neurol.2023.12.001.

Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.

Shelly S, Dubey D, Mills JR, Klein CJ

Handbook of clinical neurology 2024; (200()):239-273 doi:10.1016/B978-0-12-823912-4.00020-7.

Pathogenesis and immunopathology of paraneoplastic disorders.

Quinot V, Höftberger R

Handbook of clinical neurology 2024; (200()):33-54 doi:10.1016/B978-0-12-823912-4.00027-X.

Antibodies to neural cell surface and synaptic proteins in paraneoplastic neurologic syndromes.

Budhram A, Sechi E

Handbook of clinical neurology 2024; (200()):347-364 doi:10.1016/B978-0-12-823912-4.00006-2.

Clinical approach to diagnosis of paraneoplastic neurologic syndromes.

Graus F

Handbook of clinical neurology 2024; (200()):79-96 doi:10.1016/B978-0-12-823912-4.00007-4.

Paraneoplastic Neurologic Disorders.

Zekeridou A

Continuum (Minneapolis, Minn.) 2024; (30(4)):1021-1051 doi:10.1212/CON.0000000000001449.

Effectiveness of Intravenous Cyclophosphamide in a Patient With Anti-amphiphysin Autoimmunity Presenting With Bulbar Palsy and Cerebellar Ataxia: A Case Report.

Nomoto J, Takatsu H, Yoshida K, et al.

Cureus 2024; (16(7)):e65350 doi:10.7759/cureus.65350.

Mechanisms of immune tolerance breakdown in paraneoplastic neurological syndromes.

Peter E, Dumez P, Honnorat J, Desestret V

Revue neurologique 2024; (180(9)):931-939 doi:10.1016/j.neurol.2024.08.002.

Comprehensive Analysis of Paraneoplastic Neurologic Syndrome and PNS-CARE Diagnostic Criteria in Clinical Practice.

Zhao-Fleming H, Rezk M, Shah S, et al.

Neurology(R) neuroimmunology & neuroinflammation 2024; (11(6)):e200316 doi:10.1212/NXI.0000000000200316.

Sensory Neuronopathies: Clinical Presentation, Management, and Outcome.

Maniyar A, Ojha PT, Chheda A, et al.

Annals of Indian Academy of Neurology 2024; (27(5)):506-511 doi:10.4103/aian.aian_303_24.

Paraneoplastic Syndromes Associated with Gynecologic Neoplasms: Experience from a Tertiary Care Center in South India.

Sudhakaran S, Acharya G, Kulkarni KA, et al.

South Asian journal of cancer 2024; (13(3)):185-190 doi:10.1055/s-0043-1772223.

Effects of Home-Based Exercise Program on Chemotherapy-Induced Peripheral Neuropathy and Quality of Life: A Single-blind Randomized Controlled Trial.

Çömlekçi N, Can G, Taş F

Cancer nursing 2025; doi:10.1097/NCC.0000000000001495.

Peripheral Neuropathy: A Review.

Mauermann ML, Staff NP

JAMA 2025; doi:10.1001/jama.2025.19400.

Chronic Oxaliplatin Treatment Induces CIPN in Mice via Activation of the TXNIP Pathway.

Du J, Sudlow LC, Shahverdi K, et al.

Molecular neurobiology 2025; (63(1)):92 doi:10.1007/s12035-025-05463-7.

Longitudinal associations of chemotherapy-induced peripheral neuropathy with psychological distress and health-related quality of life in colorectal cancer survivors: a prospective cohort study.

Boekhoudt ND, Mols F, Simons C, et al.

Journal of cancer survivorship : research and practice 2025; doi:10.1007/s11764-025-01906-1.

Capsaicin in the Management of Peripheral Neuropathy: A Review.

Ryan R, Judge R, Lou J, Ng A

Current pain and headache reports 2025; (29(1)):121 doi:10.1007/s11916-025-01423-x.

Mechanisms of paraneoplastic neurological syndromes.

Kunchok A, Vogrig A, Graus F

Current opinion in neurology 2026; (39(3)):370-377 doi:10.1097/WCO.0000000000001488.

Anti-Yo related pure sensory ganglionopathy: a rare paraneoplastic entity.

Theologou R, Tsechelidis I, Artemiadis A, et al.

Acta neurologica Belgica 2026; (126(4)):1471-1474 doi:10.1007/s13760-026-03115-8.

Clinical approach to neurological paraneoplastic syndromes.

Anderson NE

Internal medicine journal 2026; (56(8)):1314-1322 doi:10.1111/imj.70500.